StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) stock

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$28.96−0.08 (-0.28%)

Close on Nov 18, 2026Market cap $3.42BP/E 8.1Yield –

Supernus net income

Net income is the profit left for shareholders after every expense, interest and tax.

Supernus's net income for the twelve months ending Sep 30, 2026 was $450.00M, up 251.6% year over year. For fiscal 2025 it was $210.00M, up 2900.0% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$210.00M+2900.0%
FY2024Dec 31, 2024$7.00M–
FY2023Dec 31, 2023-$126.00M–
FY2022Dec 31, 2022-$42.00M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$137.00M+226.2%
Q2 FY2026Jun 30, 2026$122.00M+577.8%
Q1 FY2026Mar 31, 2026$89.00M+89.4%
Q4 FY2025Dec 31, 2025$102.00M+385.7%
Q3 FY2025Sep 30, 2025$42.00M+90.9%
Q2 FY2025Jun 30, 2025$18.00M–
Q1 FY2025Mar 31, 2025$47.00M-23.0%
Q4 FY2024Dec 31, 2024$21.00M–
Q3 FY2024Sep 30, 2024$22.00M–
Q2 FY2024Jun 30, 2024-$97.00M–
Q1 FY2024Mar 31, 2024$61.00M–

More Supernus figures

See a number that looks wrong?